Molecule Details
| InChIKey | NBHPRWLFLUBAIE-UHFFFAOYSA-N |
|---|---|
| Compound Name | Halopemide |
| Canonical SMILES | O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.45 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB20096 |
|---|---|
| Drug Name | Halopemide |
| CAS Number | 59831-65-1 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Halopemide is a small molecule drug. Halopemide has a monoisotopic molecular weight of 416.14 Da. |
Categories: Benzimidazoles Heterocyclic Compounds, Fused-Ring Piperidines
Cross-references: BindingDB: 50206160 CHEMBL245621 PDB: MJV ZINC: ZINC000000537818
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| Q13393 | PLD1 | Phospholipase D1 | inhibitor | targets |